Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase

Qing Li,Wei Hu,Wei-Xin Liu,Liu-Yang Zhao,Dan Huang,Xiao-Dong Liu,Hung Chan,Yuchen Zhang,Ju-Deng Zeng,Olabisi Oluwabukola Coker,Wei Kang,Simon Siu Man Ng,Lin Zhang,Sunny Hei Wong,Tony Gin,Matthew Tak Vai Chan,Jian-Lin Wu,Jun Yu,William Ka Kei Wu
DOI: https://doi.org/10.1053/j.gastro.2020.09.003
IF: 29.4
2021-03-01
Gastroenterology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background &amp; Aims</h3><p><em>Streptococcus thermophilus</em> was identified to be depleted in patients with colorectal cancer (CRC) by shotgun metagenomic sequencing of 526 multi-cohort fecal samples. Here, we aim to investigate if this bacterium could act as a prophylactics for CRC prevention.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The anti-tumor effects of <em>S. thermophilus</em> were assessed in cultured colonic epithelial cells and in two murine models of intestinal tumorigenesis. The tumor-suppressive protein produced by <em>S. thermophilus</em> was identified by mass spectrometry and followed by β-galactosidase activity assay. The mutant strain of <em>S. thermophilus</em> was constructed by homologous recombination. The effect of <em>S. thermophilus</em> on the gut microbiota composition was assessed by shot-gun metagenomic sequencing.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Oral gavage of <em>S. thermophilus</em> significantly reduced tumor formation in both <em>Apc</em><sup>min/+</sup> and azoxymethane-injected mice. Co-incubation with <em>S. thermophilus</em> or its conditioned medium decreased the proliferation of cultured CRC cells. β-galactosidase was identified as the critical protein produced by <em>S. thermophilus</em> by mass-spectrometry screening and β-galactosidase activity assay. β-galactosidase secreted by <em>S. thermophilus</em> inhibited cell proliferation, lowered colony formation, induced cell cycle arrest, and promoted apoptosis of cultured CRC cells and retarded the growth of CRC xenograft. The mutant <em>S. thermophilus</em> without functional β-galactosidase lost its tumor-suppressive effect. Also, <em>S. thermophilus</em> increased the gut abundance of known probiotics, including <em>Bifidobacterium</em> and <em>Lactobacillus</em> via β-galactosidase. β-galactosidase-dependent production of galactose interfered with energy homeostasis to activate oxidative phosphorylation and downregulate the Hippo pathways kinases, which partially mediated the anticancer effects of <em>S. thermophilus.</em></p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p><em>S. thermophilus</em> is a novel prophylactics for CRC prevention in mice. The tumor-suppressive effect of <em>S. thermophilus</em> is mediated at least by the secretion of β-galactosidase.</p>
gastroenterology & hepatology
What problem does this paper attempt to address?